A Pilot Study Examining Thiamine Deficiency in Patients Admitted to the Hospital for Liver Transplantation


About this study

The purpose of this study is to report the proportion of thiamine deficiency (as defined by the Mayo Clinic Laboratory reference range) in liver transplant patients.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adult patients, 18+ years old.
  • Patients with end stage liver disease of any etiology with an active offer for liver transplantation.

Exclusion Criteria: 

  • Prior transplant of any organ within the preceding 24 months.
  • Vulnerable populations (prisoners, pregnant women, patients <18 years old).

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Edward Blair, APRN

Open for enrollment

Contact information:

Carolyne Stevens



More information


Publications are currently not available

Mayo Clinic Footer